Questions? Call 800-624-6242 About | Ordering | New Menu | Items in cart [0] SEARCH

PAPERBACK price:$38.50 add to cart Rights & Permissions Free PDF Access Sign in to download PDF book and chapters Free Resources Display this book on your site! Related Titles Ensuring Quality Cancer Care From Cancer Patient to Cancer Survivor: Lost in Transition Other Related Titles Assessing and Improving Value in Cancer Care: Workshop Summary (2009) National Cancer Policy Forum (NCPF) Board on Health Care Services (HCS) Citation Manager Export the bibliographic data for this book in your chosen format Web Search Builder Use this book's key terms to search within this book, across our collection, or across the Web. Skim This Chapter Skim this chapter and use this chapter's key terms to search within this book. Reference Finder Paste in your own text to find books that relate to your topic. Citation Manager . "Acronyms." Assessing and Improving Value in Cancer Care: Workshop Summary. Washington, DC: The National Academies Press, 2009. Please select a format: Page 117   E-mail Share on facebook Facebook Share on delicious Delicious Share on stumbleupon Stumble Share on twitter Twitter More Sharing ServicesMore The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. Acronyms ACS American Cancer Society ASCO American Society of Clinical Oncology ASP average sales price ATC4 anatomical therapeutic classification AWP average wholesale price CCDR Canadian Coordinated Drug Review CED coverage with evidence development CMS Centers for Medicare and Medicaid Services FDA U.S. Food and Drug Administration GDP gross domestic product HTA health technology assessment ICD implantable cardiac defibrillator ICER incremental cost-effectiveness ratio IND investigational new drug IOM Institute of Medicine Page 117 Front Matter (R1-R16) 1 Introduction (1-2) 2 Opening Remarks: What Is Value in Cancer Care and Why Is It Important? (3-6) PART I: Challenges to Value in Cancer Care (7-8) 3 Clinician–Patient Communication and Its Influence on Value (9-22) 4 Generating Evidence About Effectiveness and Value (23-32) 5 Value and the Oncology Market (33-54) 6 Value in Oncology Practice: Oncologist and Health Insurer Perspectives (55-68) 7 Ethical Issues and Value in Oncology (69-82) PART II:Solutions for Value in Cancer Care (83-84) 8 Improving Value in Oncology Practice: Ways Forward (85-108) 9 Toward a Shared Understanding of Value (109-116) Acronyms (117-118) Glossary (119-124) Appendix A: Workshop Agenda (125-128) Appendix B: Speaker and Moderator Biographies (129-148)

Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 117
Assessing and Improving Value in Cancer Care: Workshop Summary Acronyms ACS American Cancer Society ASCO American Society of Clinical Oncology ASP average sales price ATC4 anatomical therapeutic classification AWP average wholesale price CCDR Canadian Coordinated Drug Review CED coverage with evidence development CMS Centers for Medicare and Medicaid Services FDA U.S. Food and Drug Administration GDP gross domestic product HTA health technology assessment ICD implantable cardiac defibrillator ICER incremental cost-effectiveness ratio IND investigational new drug IOM Institute of Medicine

OCR for page 118
Assessing and Improving Value in Cancer Care: Workshop Summary NCCN National Comprehensive Cancer Network NCI National Cancer Institute NCPF National Cancer Policy Forum NHS National Health Service (United Kingdom) NICE U.K. National Institute for Health and Clinical Excellence NIH National Institutes of Health NSCLC non-small cell lung cancer PBM pharmacy benefit manager PhRMA Pharmaceutical Research and Manufacturers of America QALY quality-adjusted life-year RCT randomized controlled trial RVU relative value unit VBID value-based insurance design